Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells (Q38813588)

6 September 2017

Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells (English)

1 reference

6 September 2017

0 references

1 reference

Cigir Biray Avci

1

1 reference

6 September 2017

Cansu Caliskan Kurt

2

1 reference

6 September 2017

Burcu Erbaykent Tepedelen

3

1 reference

6 September 2017

Ozgun Ozalp

4

1 reference

6 September 2017

Bakiye Goker

5

1 reference

6 September 2017

Zeynep Mutlu

6

1 reference

6 September 2017

Yavuz Dodurga

7

1 reference

6 September 2017

Levent Elmas

8

1 reference

6 September 2017

Cumhur Gunduz

9

1 reference

6 September 2017

8 December 2015

1 reference

6 September 2017

1 reference

6 September 2017

37

1 reference

6 September 2017

5

1 reference

6 September 2017

6673-6679

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-4519-3

6 September 2017

0 references

cites work

An integrated genomic analysis of human glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Glioblastoma stem cells: Molecular characteristics and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Using the molecular classification of glioblastoma to inform personalized treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Glioblastoma multiforme therapy and mechanisms of resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Endocytotic uptake of zoledronic acid by tubular cells may explain its renal effects in cancer patients receiving high doses of the compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Antitumor effects and anticancer applications of bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

The role of bisphosphonates in the management of patients that have cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Bisphosphonates as anticancer therapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Potential anticancer properties of bisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

The critical role of bisphosphonates to target bone cancer metastasis: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Antitumor effects of bisphosphonates: from the laboratory to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Bisphosphonates induce apoptosis in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Anticancer properties of zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid - a multiplicity of anti-cancer action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Anticancer effects of zoledronic acid against human osteosarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid exerts antitumor effects in NB4 acute promyelocytic leukemia cells by inducing apoptosis and S phase arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Bisphosphonates induce breast cancer cell death in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Differential effects of bisphosphonates on breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Zoledronic acid enhances Vδ2 T-lymphocyte antitumor response to human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Retracted: Enhanced Anti-Tumor Effect of Zoledronic Acid Combined with Temozolomide against Human Malignant Glioma Cell Expressing O6-Methylguanine DNA Methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4519-3

Skeletal complications of malignancy

21 January 2018

1 reference

12 December 2020

Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents

1 reference

12 December 2020

Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cells.

1 reference

12 December 2020

Bisphosphonates regulate cell proliferation, apoptosis and pro-osteoclastic expression in MG-63 human osteosarcoma cells

1 reference

12 December 2020

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway

1 reference

12 December 2020

Bisphosphonates in cancer therapy

1 reference

12 December 2020

10.1007/S13277-015-4519-3

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference